Edesa Biotech, Inc. (EDSA) — Stock Score Summary

Edesa Biotech, Inc. (EDSA) has a MoatMap StockRank of 26/100 based on Quality (28/100), Value (34/100), and Momentum (51/100) factor scores. The current signal is SELL. Edesa Biotech is a micro-cap clinical-stage biopharmaceutical company. It has no approved products, no revenues, and high cash burn, making it entirely unsuitable for our concentrated quality portfolio.

Edesa Biotech, Inc. is a Canadian clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for inflammatory and infectious diseases. The company's competitive position is driven by its lead candidate, EB05, a monoclonal antibody targeting TLR4, which is being evaluated for the treatment of Acute Respiratory Distress Syndrome (ARDS) in hospitalized patients. Edesa operates as a specialized biotech developer, targeting high-mortality critical care conditions and chronic dermatological indications.

Key Financial Metrics

Price$4.94
Market Cap$70M
Price/Book15.86
Return on Equity-96.4%
Return on Invested Capital-57.2%
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-5M

Edesa Biotech, Inc. operates in the Biotechnology industry, part of the Healthcare sector (Canada).

Frequently Asked Questions

What is Edesa Biotech, Inc.’s (EDSA) StockRank?
MoatMap’s StockRank for Edesa Biotech, Inc. (EDSA) is 26/100, with a Sell signal. It is a composite of Quality (28), Value (34), and Momentum (51) factor ranks across MoatMap’s 19,000+ stock universe.
Does Edesa Biotech, Inc. have an economic moat?
Edesa Biotech, Inc. (EDSA) has a Quality factor score of 28/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Edesa Biotech, Inc. a buy, hold, or sell?
MoatMap’s current signal for Edesa Biotech, Inc. (EDSA) is Sell, based on a StockRank of 26/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Edesa Biotech, Inc. in?
Edesa Biotech, Inc. (EDSA) operates in the Healthcare sector, specifically the Biotechnology industry (Canada).
Browse all ranked stocksEDSA deep dive reportAI ChampionsHow we score stocksSense-check another stock